754211-05-7Relevant academic research and scientific papers
TYK2 INHIBITORS AND USES THEREOF
-
Paragraph 1407; 1420-1421, (2020/05/14)
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.
TYK2 INHIBITORS AND USES THEREOF
-
Paragraph 1046; 1051; 1052, (2019/02/13)
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.
4-[[(7-AMINOPYRAZOLO[1,5-A]PYRIMIDIN-5-YL)AMINO]METHYL]PIPERIDIN-3-OL COMPOUNDS AS CDK INHIBITORS
-
Page/Page column 36, (2019/04/16)
The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain 4-[[(7-aminopyrazolo[1,5- a]pyrimidin-5-yl)amino]methyl]piperidin-3-ol compounds (referred to herein as "APPAMP com
PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES
-
Page 155-156, (2008/06/13)
The Pyrazolo[1,5-a]pyrimidine derivatives represented by formula I and their pharmaceutically acceptable salts exhibit excellent kinase inhibiting activity. Drugs comprising the compounds as effective ingredients are therefore expected to be useful as the
